Adverse effects and Safety in Glaucoma Patients – Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD) – A Delphi Consensus Statement. 26 May, 2022 | 10:14h | UTC Adverse effects and Safety in Glaucoma Patients – Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD) – A Delphi Consensus Statement – American Journal of Ophthalmology